成纤维细胞生长因子受体 2：胃癌治疗靶点。
Fibroblast growth factor receptor 2: a therapeutic target in gastric cancer.
机构信息
State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shaanxi Province, China.
出版信息
Expert Rev Gastroenterol Hepatol. 2013 Nov;7(8):759-65. doi: 10.1586/17474124.2013.837804. Epub 2013 Oct 17.
Gastric cancer remains a leading cause of cancer-related death in the world. FGF receptor 2 (FGFR2) is preferentially amplified and overexpressed in the diffuse type of gastric cancer. This review evaluates the expression and function of FGFR2 in gastric cancer, and analyzes the use of its inhibitors for gastric cancer therapy. This review also discusses the limitations of FGFR2-based therapy, and envisages future developments toward the clinical applications of FGFR2.
胃癌仍然是全球癌症相关死亡的主要原因。成纤维细胞生长因子受体 2（FGFR2）在弥漫型胃癌中优先扩增和过表达。本综述评估了 FGFR2 在胃癌中的表达和功能，并分析了其抑制剂在胃癌治疗中的应用。本综述还讨论了基于 FGFR2 治疗的局限性，并展望了 FGFR2 临床应用的未来发展。
Zotero 插件